0001104659-19-027585.txt : 20190507 0001104659-19-027585.hdr.sgml : 20190507 20190507194058 ACCESSION NUMBER: 0001104659-19-027585 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190101 FILED AS OF DATE: 20190507 DATE AS OF CHANGE: 20190507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nally Michael CENTRAL INDEX KEY: 0001763945 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 19804776 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 3/A 1 a3a.xml 3/A X0206 3/A 2019-01-01 2019-01-10 0 0000310158 Merck & Co., Inc. MRK 0001763945 Nally Michael MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 0 1 0 0 EVP, Chief Marketing Officer Common Stock 100.0000 D Common Stock - 401(k) Plan 1365.9535 I By 401(k) Restricted Stock Unit 2019-05-04 2021-05-04 Common Stock 3896.0000 D Restricted Stock Unit 2019-05-10 2019-05-10 Common Stock 1811.0000 D Restricted Stock Unit 2019-10-30 2021-10-30 Common Stock 6862.0000 D Restricted Stock Unit 2020-05-05 2020-05-05 Common Stock 2345.0000 D Stock Option (right to buy) 54.6800 2017-05-10 2026-05-09 Common Stock 7471.0000 D Stock Option (right to buy) 57.7500 2019-05-04 2028-05-03 Common Stock 27447.0000 D Stock Option (right to buy) 63.9700 2018-05-05 2027-05-04 Common Stock 14266.0000 D The original Form 3, filed on January 10, 2019, is being amended by this Form 3 amendment solely to correct the total number of shares beneficially owned by the reporting person to include 100 shares of Merck common stock held in a joint account with the reporting person and the reporting person's parent. Includes shares acquired and dividends earned through January 1, 2019, in the Merck U.S. Savings Plan, a 401(k) plan. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/19 and 5/5/2020. Faye C. Brown as Attorney-in-Fact for Michael Nally 2019-05-07